Cart
sales@molnova.com
Emitefur
CAS No. 110690-43-2
Emitefur( —— )
Catalog No. M34239 CAS No. 110690-43-2
Emitefur (BOF-A 2) is an orally active and potent 5-fluorouracil derivative with anticancer and antitumor activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 296 | Get Quote |
|
| 5MG | 459 | Get Quote |
|
| 10MG | 657 | Get Quote |
|
| 25MG | 994 | Get Quote |
|
| 50MG | 1371 | Get Quote |
|
| 100MG | 1773 | Get Quote |
|
| 500MG | 3537 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameEmitefur
-
NoteResearch use only, not for human use.
-
Brief DescriptionEmitefur (BOF-A 2) is an orally active and potent 5-fluorouracil derivative with anticancer and antitumor activity.
-
DescriptionEmitefur is an orally active and potent anticancer drug. Emitefur can be used for advanced gastric cancer patients.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number110690-43-2
-
Formula Weight558.47
-
Molecular FormulaC28H19FN4O8
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(=O)(N1C(=O)N(COCC)C=C(F)C1=O)C2=CC(C(OC3=C(C#N)C=CC(OC(=O)C4=CC=CC=C4)=N3)=O)=CC=C2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Sugimachi K, et al. A phase II trial of a new 5-fluorouracil derivative, BOF-A2 (Emitefur), for patients with advanced gastric cancer. Surg Today. 2000;30(12):1067-72.?
molnova catalog
related products
-
Leuprolide Acetate
Leuprolide is an agonist at pituitary GnRH receptors. Leuprorelin is a gonadotropin-releasing hormone (GnRH) analog used to treat a wide range of sex hormone-related disorders including advanced prostatic cancer endometriosis and precocious puberty.
-
SBI-425
SBI-425 is an effective and orally bioavailable inhibitor of tissue-nonspecific alkaline phosphatase (TNAP).
-
Cyanidin-3-O-arabino...
Cyanidin-3-O-arabinoside chloride has antioxidant activity. It reduces the peroxynitrite-induced suppression of mitochondrial respiration, DNA damage, PARS activation and vascular dysfunction in HUVECs.
